Starbucks is about to report earnings. Here’s what to expect

Starbucks is about to report earnings. Here’s what to expect


A pedestrian holds a Starbucks cup in Sacramento, California, on April 28, 2025.

David Paul Morris | Bloomberg | Getty Images

Starbucks is expected to report its fiscal second-quarter earnings after the bell on Tuesday.

Here’s what Wall Street analysts surveyed by LSEG are expecting the company to report:

  • Earnings per share: 49 cents expected
  • Revenue: $8.82 billion expected

Analysts are expecting Starbucks’ same-store sales to decline for the fifth straight quarter. The company’s North American same-store sales are projected to fall 0.8%, while the metric is expected to shrink 1.7% internationally, according to StreetAccount estimates.

The coffee giant has been in turnaround mode since September, when CEO Brian Niccol joined the company. Early steps to revive its U.S. sales include changing its advertising strategy, writing personalized messages on coffee cups again and improving the algorithm used by its mobile app.

So far, the only major restaurant company to report earnings for the first three months of the year has been Niccol’s former employer, Chipotle. The burrito chain reported same-store sales declines and cut its full-year forecast, citing a slowdown in consumer spending and bad weather.

Shares of Starbucks have fallen 8% this year, as investors worry about tariffs and how they will affect consumer spending. The company has a market cap of more than $95 billion.

Don’t miss these insights from CNBC PRO



Source

These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More
Wealthy donors stand to win double tax benefit if ‘Trump Accounts’ allow stock donations
Business

Wealthy donors stand to win double tax benefit if ‘Trump Accounts’ allow stock donations

President Donald Trump onstage at the Treasury Department’s Trump Accounts Summit, in Washington, Jan. 28, 2026. Kevin Lamarque | Reuters A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. With the Trump […]

Read More